Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to Rilpivirine in Virologically-suppressed HIV Adolescents
NCT03033368Phase 3Unknown
- Sponsor
- Mahidol University
- Start
- Jul 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rilpivirine in human immunodeficiency virus infection (HIV), sponsored by Mahidol University. Status: unknown.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03033368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03033368.